Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$2.14 USD
+0.23 (12.04%)
Updated Dec 6, 2024 04:00 PM ET
After-Market: $2.13 -0.01 (-0.47%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Price, Consensus and EPS Surprise
EDIT 2.14 +0.23(12.04%)
Will EDIT be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for EDIT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EDIT
Why Is Editas (EDIT) Down 36.5% Since Last Earnings Report?
CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Editas Medicine (EDIT) Reports Q3 Loss, Misses Revenue Estimates
Other News for EDIT
Editas Medicine, Inc. (EDIT) 7th Annual Evercore HealthCONx Conference (Transcript)
Editas Medicine (EDIT) Stock Drops 5.13% Amidst Biotech Sector Volatility
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 30
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today